Inhibition of SRC-mediated integrin signaling in bone marrow niche enhances hematopoietic stem cell function

  • iScience. 2022 Sep 19;25(10):105171. doi: 10.1016/j.isci.2022.105171.
Irene Mariam Roy  1 P V Anu  1 Samantha Zaunz  2 Srinu Reddi  1 Aravind M Giri  1 Rithika Saroj Sankar  1 Sarah Schouteden  2 Joerg Huelsken  3 Catherine M Verfaillie  2 Satish Khurana  1
Affiliations
  • 1. School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Kerala 695551, India.
  • 2. Stem Cell Institute, KU Leuven, 3000 Leuven, Belgium.
  • 3. École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Abstract

Interaction with microenvironmental factors is crucial for the regulation of hematopoietic stem cell (HSC) function. Stroma derived factor (SDF)-1α supports HSCs in the quiescent state and is central to the homing of transplanted HSCs. Here, we show that Integrin signaling regulates Sdf-1α expression transcriptionally. Systemic deletion of Periostin, an Integrin-αv ligand, showed increased expression of Sdf-1α in bone marrow (BM) niche. Pharmacological inhibition or CRISPR-Cas9-mediated deletion of Src, resulted in a similar increase in the chemokine expression in vitro. Importantly, systemic SRC-inhibition led to increase in SDF-1α levels in BM plasma. This resulted in a robust increase (14.05 ± 1.22% to 29.11 ± 0.69%) in the homing efficiency of transplanted HSCs. In addition, we observed enhancement in the recovery of blood cell counts following radiation injury, indicating an enhanced hematopoietic function. These results establish a role of SRC-mediated Integrin signaling in the transcriptional regulation of Sdf-1α. This mechanism could be harnessed further to improve the hematopoietic function.

Keywords
Biological sciences; cell biology; stem cells research.
Products